title: Noncardiac surgery after coronary stenting: early surgery and interruption of antiplatelet therapy are associated with an increase in major adverse cardiac events.
authors.forename: Olaf
authors.initials: O
authors.lastname: Schouten
authors.forename: Ron T
authors.initials: RT
authors.lastname: van Domburg
authors.forename: Jeroen J
authors.initials: JJ
authors.lastname: Bax
authors.forename: Peter J
authors.initials: PJ
authors.lastname: de Jaegere
authors.forename: Martin
authors.initials: M
authors.lastname: Dunkelgrun
authors.forename: Harm H H
authors.initials: HH
authors.lastname: Feringa
authors.forename: Sanne E
authors.initials: SE
authors.lastname: Hoeks
authors.forename: Don
authors.initials: D
authors.lastname: Poldermans
mesh_terms: D000368:Aged; D015906:Angioplasty, Balloon, Coronary; D003324:Coronary Artery Disease / Q000628:therapy; D003643:Death; D016503:Drug Delivery Systems; D006331:Heart Diseases / Q000209:etiology / Q000401:mortality*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage; D008297:Male; D008875:Middle Aged; D009203:Myocardial Infarction / Q000209:etiology; D010975:Platelet Aggregation Inhibitors / Q000627:therapeutic use*; D012042:Registries; D012189:Retrospective Studies; D015607:Stents; D013514:Surgical Procedures, Operative / Q000009:adverse effects*; D013997:Time Factors
chemical_list: D007166:Immunosuppressive Agents; D010975:Platelet Aggregation Inhibitors